Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Endo International PLC

4 Penny Stocks to Target Following the Latest Jobs Report

June inflation rose at the fastest pace since November 1981. However, the latest job report presented a healthy picture of the economy. Thus, we think penny stocks Annexon (ANNX), Aprea Therapeutics (APRE), Yatsen (YSG), and Endo International (ENDP), which have been outperforming the market over the past month, could be…

Why Endo International Shares Are Getting Hammered Today

Why Endo International Shares Are Getting Hammered Today

Endo International PLC (NASDAQ: ENDP) shares are trading lower by 16.86% to $0.39 after the company provided top-line results from its Phase 2 study of CCH in patients with adhesive capsulitis of the shoulder, saying "the difference compared to those study participants receiving placebo was not st

Endo Posts Disappointing Data From Frozen Shoulder Trial

Endo Posts Disappointing Data From Frozen Shoulder Trial

Endo International plc (NASDAQ:ENDP) has announced topline results from its Phase 2 study of collagenase clostridium histolyticum (CCH) in participants with adhesive capsulitis (AC) of the shoulder (frozen shoulder). While participants receiving up to three doses of CCH showed some improvement in the change from baseline in the shoulder pathology composite score, the…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Endo Inks US Pact For Osteoarthritis Pain Injectable

TLC BioSciences has entered a commercialization agreement with Endo International plc (NASDAQ:ENDP) for the U.S. rights of TLC599, a proprietary BioSeizer sustained-release injectable in Phase 3 development for osteoarthritis pain. Under the agreement signed with Endo's subsidiary Endo Ventures Limited (EVL), TLC will primarily be responsible for developing the product, and EVL for obtaining regulatory…

What Is Happening With Endo Shares Today

Endo International Plc (NASDAQ:ENDP) initiated negotiations with its lenders and senior bondholders regarding a possible reorganization of more than $8 billion of its debt, the Wall Street Journal reported, citing people familiar with the matter. Lenders began talks after the company reported disappointing earnings early this month for 1Q 2022, driven by the loss…

Endo Shares Plummet On Decreasing Sales, Wider Loss; Outlook Lagging Consensus

Endo International plc's (NASDAQ:ENDP) Q1 sales decreased 9% to $652.26 million, beating the consensus of $633.41 million. The decrease was attributable to decreased revenues from the sterile injectables segment, partially offset by increased revenues from the generic segment and the specialty products portfolio. Adjusted income from continuing operations reached $156 million compared…

Why Endo International Shares Are Getting Hammered Today

Endo International PLC (NASDAQ: ENDP) shares are trading lower by 34.65% at $1.32 after the company reported first-quarter earnings results and issued second-quarter guidance.

inkl

Read news from The Economist, FT, and more,
with one subscription

Endo Acquires Six Development-Stage, Injectable Product Candidates For $35M

Endo Acquires Six Development-Stage, Injectable Product Candidates For $35M

Endo International plc (NASDAQ: ENDP) has acquired six development-stage, ready-to-use injectable product candidates from Nevakar Injectables Inc, a subsidiary of Nevakar Inc.

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters

San Francisco will start a trial against Walgreens Boots Alliance Inc (NASDAQ:WBA) and three other companies accused of fueling an opioid crisis in the city. San Francisco has alleged that Walgreens, Teva Pharmaceutical Industries Ltd (NYSE:TEVA), AbbVie Inc's (NYSE:ABBV) Allergan unit, and Teva-owned Anda Inc created a "public nuisance" by flooding the city with prescription opioids and failing…

JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters

JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters

Alabama reached $276 million in settlements with Johnson & Johnson (NYSE:JNJ), McKesson Corporation (NYSE:MCK), and Endo International Plc (NASDAQ:ENDP), resolving claims on the opioid addiction crisis, the state attorney general said. McKesson will pay $141 million. JNJ and Endo will pay $70.3 million and $25 million, respectively, Alabama Attorney General Steve Marshall said in a statement. The three…

Why Endo International Shares Are Falling

Why Endo International Shares Are Falling

Endo International PLC (NASDAQ: ENDP) shares are trading lower after the company issued first-quarter EPS and sales guidance below analyst estimates.

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Wall Street Journal

McKesson Corporation

Cardinal Health Inc

CVS Health Corp

Walgreens Boots Alliance Inc

Endo International

Teva Pharmaceutical Industries Ltd

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

367,630 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play